Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001731122-21-001296
Filing Date
2021-08-04
Accepted
2021-08-04 17:26:04
Documents
1
Period of Report
2021-08-02

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3685
  Complete submission text file 0001731122-21-001296.txt   5133
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Issuer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address FALLMERAYER STR. 19 MUNICH 2M 80796
Business Address
Thomas Steffen (Reporting) CIK: 0001646396 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37606 | Film No.: 211145244